Intracellular Uropathogenic . Exploits Host Rab35 for Iron Acquisition and Survival within Urinary Bladder Cells
Urinary tract infections (UTIs) are common and costly infectious diseases, affecting half of all women. Many women suffer from recurrent UTIs, for which no effective therapy currently exists. Intracellular persistence within bladder epithelial cells (BEC) by uropathogenic E. coli (UPEC) contributes to recurrent UTI in mouse models of infection. In the current study, we specifically asked whether and how UPEC co-opt any of the host proteins regulating vesicular trafficking for intracellular infection. Our study demonstrates a novel mechanism by which UPEC exploit a host endocytic recycling pathway protein (Rab35) to acquire the critical nutrient iron and to prevent lysosomal degradation, thereby promoting intracellular survival within BEC. The results of this study may highlight new avenues for therapeutic intervention in recurrent UTI. In addition, knowledge gained from this study can also be extended to understand the general principles by which other intracellular bacterial pathogens acquire essential nutrients, leading to additional strategies to combat these infectious diseases.
Vyšlo v časopise:
Intracellular Uropathogenic . Exploits Host Rab35 for Iron Acquisition and Survival within Urinary Bladder Cells. PLoS Pathog 11(8): e32767. doi:10.1371/journal.ppat.1005083
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1005083
Souhrn
Urinary tract infections (UTIs) are common and costly infectious diseases, affecting half of all women. Many women suffer from recurrent UTIs, for which no effective therapy currently exists. Intracellular persistence within bladder epithelial cells (BEC) by uropathogenic E. coli (UPEC) contributes to recurrent UTI in mouse models of infection. In the current study, we specifically asked whether and how UPEC co-opt any of the host proteins regulating vesicular trafficking for intracellular infection. Our study demonstrates a novel mechanism by which UPEC exploit a host endocytic recycling pathway protein (Rab35) to acquire the critical nutrient iron and to prevent lysosomal degradation, thereby promoting intracellular survival within BEC. The results of this study may highlight new avenues for therapeutic intervention in recurrent UTI. In addition, knowledge gained from this study can also be extended to understand the general principles by which other intracellular bacterial pathogens acquire essential nutrients, leading to additional strategies to combat these infectious diseases.
Zdroje
1. Foxman B (2010) The epidemiology of urinary tract infection. Nat Rev Urol 7: 653–660. doi: 10.1038/nrurol.2010.190 21139641
2. Litwin MS, Saigal CS, Yano EM, Avila C, Geschwind SA, et al. (2005) Urologic diseases in America Project: analytical methods and principal findings. J Urol 173: 933–937. 15711342
3. Ronald A (2003) The etiology of urinary tract infection: traditional and emerging pathogens. Dis Mon 49: 71–82. 12601338
4. Brauner A, Jacobson SH, Kuhn I (1992) Urinary Escherichia coli causing recurrent infections—a prospective follow-up of biochemical phenotypes. Clin Nephrol 38: 318–323. 1468162
5. Russo TA, Stapleton A, Wenderoth S, Hooton TM, Stamm WE (1995) Chromosomal restriction fragment length polymorphism analysis of Escherichia coli strains causing recurrent urinary tract infections in young women. J Infect Dis 172: 440–445. 7622887
6. Hung CS, Dodson KW, Hultgren SJ (2009) A murine model of urinary tract infection. Nat Protoc 4: 1230–1243. doi: 10.1038/nprot.2009.116 19644462
7. Sivick KE, Mobley HL (2010) Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect Immun 78: 568–585. doi: 10.1128/IAI.01000-09 19917708
8. Ulett GC, Totsika M, Schaale K, Carey AJ, Sweet MJ, et al. (2013) Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection. Curr Opin Microbiol 16: 100–107. doi: 10.1016/j.mib.2013.01.005 23403118
9. Schilling JD, Lorenz RG, Hultgren SJ (2002) Effect of trimethoprim-sulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli. Infect Immun 70: 7042–7049. 12438384
10. Hunstad DA, Justice SS (2010) Intracellular lifestyles and immune evasion strategies of uropathogenic Escherichia coli. Annu Rev Microbiol 64: 203–221. doi: 10.1146/annurev.micro.112408.134258 20825346
11. Mysorekar IU, Hultgren SJ (2006) Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proc Natl Acad Sci U S A 103: 14170–14175. 16968784
12. Robino L, Scavone P, Araujo L, Algorta G, Zunino P, et al. (2014) Intracellular Bacteria in the Pathogenesis of Escherichia coli Urinary Tract Infection in Children. Clin Infect Dis.
13. Robino L, Scavone P, Araujo L, Algorta G, Zunino P, et al. (2013) Detection of intracellular bacterial communities in a child with Escherichia coli recurrent urinary tract infections. Pathog Dis 68: 78–81. doi: 10.1111/2049-632X.12047 23733378
14. Rosen DA, Hooton TM, Stamm WE, Humphrey PA, Hultgren SJ (2007) Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med 4: e329. 18092884
15. Khasriya R, Sathiananthamoorthy S, Ismail S, Kelsey M, Wilson M, et al. (2013) Spectrum of bacterial colonization associated with urothelial cells from patients with chronic lower urinary tract symptoms. J Clin Microbiol 51: 2054–2062. doi: 10.1128/JCM.03314-12 23596238
16. Zhou G, Mo WJ, Sebbel P, Min G, Neubert TA, et al. (2001) Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding. J Cell Sci 114: 4095–4103. 11739641
17. Eto DS, Jones TA, Sundsbak JL, Mulvey MA (2007) Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli. PLoS Pathog 3: e100. 17630833
18. Hung CS, Bouckaert J, Hung D, Pinkner J, Widberg C, et al. (2002) Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection. Mol Microbiol 44: 903–915. 12010488
19. Bishop BL, Duncan MJ, Song J, Li G, Zaas D, et al. (2007) Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells. Nat Med 13: 625–630. 17417648
20. Dhakal BK, Kulesus RR, Mulvey MA (2008) Mechanisms and consequences of bladder cell invasion by uropathogenic Escherichia coli. Eur J Clin Invest 38 Suppl 2: 2–11. doi: 10.1111/j.1365-2362.2008.01986.x 18616559
21. Duncan MJ, Li G, Shin JS, Carson JL, Abraham SN (2004) Bacterial penetration of bladder epithelium through lipid rafts. J Biol Chem 279: 18944–18951. 14976212
22. Eto DS, Gordon HB, Dhakal BK, Jones TA, Mulvey MA (2008) Clathrin, AP-2, and the NPXY-binding subset of alternate endocytic adaptors facilitate FimH-mediated bacterial invasion of host cells. Cell Microbiol 10: 2553–2567. doi: 10.1111/j.1462-5822.2008.01229.x 18754852
23. Martinez JJ, Hultgren SJ (2002) Requirement of Rho-family GTPases in the invasion of Type 1-piliated uropathogenic Escherichia coli. Cell Microbiol 4: 19–28. 11856170
24. Martinez JJ, Mulvey MA, Schilling JD, Pinkner JS, Hultgren SJ (2000) Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. EMBO J 19: 2803–2812. 10856226
25. Song J, Bishop BL, Li G, Grady R, Stapleton A, et al. (2009) TLR4-mediated expulsion of bacteria from infected bladder epithelial cells. Proc Natl Acad Sci U S A 106: 14966–14971. doi: 10.1073/pnas.0900527106 19706440
26. Anderson GG, Palermo JJ, Schilling JD, Roth R, Heuser J, et al. (2003) Intracellular bacterial biofilm-like pods in urinary tract infections. Science 301: 105–107. 12843396
27. Justice SS, Hung C, Theriot JA, Fletcher DA, Anderson GG, et al. (2004) Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc Natl Acad Sci U S A 101: 1333–1338. 14739341
28. Mulvey MA, Lopez-Boado YS, Wilson CL, Roth R, Parks WC, et al. (1998) Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 282: 1494–1497. 9822381
29. Wang C, Mendonsa GR, Symington JW, Zhang Q, Cadwell K, et al. (2012) Atg16L1 deficiency confers protection from uropathogenic Escherichia coli infection in vivo. Proc Natl Acad Sci U S A 109: 11008–11013. doi: 10.1073/pnas.1203952109 22715292
30. Skaar EP (2010) The battle for iron between bacterial pathogens and their vertebrate hosts. PLoS Pathog 6: e1000949. doi: 10.1371/journal.ppat.1000949 20711357
31. Henderson JP, Crowley JR, Pinkner JS, Walker JN, Tsukayama P, et al. (2009) Quantitative metabolomics reveals an epigenetic blueprint for iron acquisition in uropathogenic Escherichia coli. PLoS Pathog 5: e1000305. doi: 10.1371/journal.ppat.1000305 19229321
32. Reigstad CS, Hultgren SJ, Gordon JI (2007) Functional genomic studies of uropathogenic Escherichia coli and host urothelial cells when intracellular bacterial communities are assembled. J Biol Chem 282: 21259–21267. 17504765
33. Snyder JA, Haugen BJ, Buckles EL, Lockatell CV, Johnson DE, et al. (2004) Transcriptome of uropathogenic Escherichia coli during urinary tract infection. Infect Immun 72: 6373–6381. 15501767
34. Bielecki P, Muthukumarasamy U, Eckweiler D, Bielecka A, Pohl S, et al. (2014) In vivo mRNA profiling of uropathogenic Escherichia coli from diverse phylogroups reveals common and group-specific gene expression profiles. MBio 5: e01075–01014. doi: 10.1128/mBio.01075-14 25096872
35. Hagan EC, Lloyd AL, Rasko DA, Faerber GJ, Mobley HL (2010) Escherichia coli global gene expression in urine from women with urinary tract infection. PLoS Pathog 6: e1001187. doi: 10.1371/journal.ppat.1001187 21085611
36. Alteri CJ, Hagan EC, Sivick KE, Smith SN, Mobley HL (2009) Mucosal immunization with iron receptor antigens protects against urinary tract infection. PLoS Pathog 5: e1000586. doi: 10.1371/journal.ppat.1000586 19806177
37. Hagan EC, Mobley HL (2007) Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection. Infect Immun 75: 3941–3949. 17517861
38. Torres AG, Redford P, Welch RA, Payne SM (2001) TonB-dependent systems of uropathogenic Escherichia coli: aerobactin and heme transport and TonB are required for virulence in the mouse. Infect Immun 69: 6179–6185. 11553558
39. Sivick KE, Mobley HL (2009) An "omics" approach to uropathogenic Escherichia coli vaccinology. Trends Microbiol 17: 431–432. doi: 10.1016/j.tim.2009.07.003 19758805
40. Zhao N, Enns CA (2012) Iron transport machinery of human cells: players and their interactions. Curr Top Membr 69: 67–93. doi: 10.1016/B978-0-12-394390-3.00003-3 23046647
41. Stenmark H (2009) Rab GTPases as coordinators of vesicle traffic. Nat Rev Mol Cell Biol 10: 513–525. doi: 10.1038/nrm2728 19603039
42. Mizuno-Yamasaki E, Rivera-Molina F, Novick P (2012) GTPase networks in membrane traffic. Annu Rev Biochem 81: 637–659. doi: 10.1146/annurev-biochem-052810-093700 22463690
43. Brumell JH, Scidmore MA (2007) Manipulation of rab GTPase function by intracellular bacterial pathogens. Microbiol Mol Biol Rev 71: 636–652. 18063721
44. Halaas O, Steigedal M, Haug M, Awuh JA, Ryan L, et al. (2010) Intracellular Mycobacterium avium intersect transferrin in the Rab11(+) recycling endocytic pathway and avoid lipocalin 2 trafficking to the lysosomal pathway. J Infect Dis 201: 783–792. doi: 10.1086/650493 20121435
45. Chua CE, Lim YS, Tang BL (2010) Rab35—a vesicular traffic-regulating small GTPase with actin modulating roles. FEBS Lett 584: 1–6. doi: 10.1016/j.febslet.2009.11.051 19931531
46. Patino-Lopez G, Dong X, Ben-Aissa K, Bernot KM, Itoh T, et al. (2008) Rab35 and its GAP EPI64C in T cells regulate receptor recycling and immunological synapse formation. J Biol Chem 283: 18323–18330. doi: 10.1074/jbc.M800056200 18450757
47. Grant BD, Donaldson JG (2009) Pathways and mechanisms of endocytic recycling. Nat Rev Mol Cell Biol 10: 597–608. doi: 10.1038/nrm2755 19696797
48. Mayle KM, Le AM, Kamei DT (2012) The intracellular trafficking pathway of transferrin. Biochim Biophys Acta 1820: 264–281. doi: 10.1016/j.bbagen.2011.09.009 21968002
49. Ponka P, Lok CN (1999) The transferrin receptor: role in health and disease. Int J Biochem Cell Biol 31: 1111–1137. 10582342
50. Huang B, Hubber A, McDonough JA, Roy CR, Scidmore MA, et al. (2010) The Anaplasma phagocytophilum-occupied vacuole selectively recruits Rab-GTPases that are predominantly associated with recycling endosomes. Cell Microbiol 12: 1292–1307. doi: 10.1111/j.1462-5822.2010.01468.x 20345488
51. Chesneau L, Dambournet D, Machicoane M, Kouranti I, Fukuda M, et al. (2012) An ARF6/Rab35 GTPase cascade for endocytic recycling and successful cytokinesis. Curr Biol 22: 147–153. doi: 10.1016/j.cub.2011.11.058 22226746
52. Mulvey MA, Schilling JD, Hultgren SJ (2001) Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun 69: 4572–4579. 11402001
53. Al-Younes HM, Rudel T, Meyer TF (1999) Characterization and intracellular trafficking pattern of vacuoles containing Chlamydia pneumoniae in human epithelial cells. Cell Microbiol 1: 237–247. 11207556
54. Delbruck R, Desel C, von Figura K, Hille-Rehfeld A (1994) Proteolytic processing of cathepsin D in prelysosomal organelles. Eur J Cell Biol 64: 7–14. 7957314
55. Rijnboutt S, Stoorvogel W, Geuze HJ, Strous GJ (1992) Identification of subcellular compartments involved in biosynthetic processing of cathepsin D. J Biol Chem 267: 15665–15672. 1322403
56. Hagan EC, Mobley HL (2009) Haem acquisition is facilitated by a novel receptor Hma and required by uropathogenic Escherichia coli for kidney infection. Mol Microbiol 71: 79–91. doi: 10.1111/j.1365-2958.2008.06509.x 19019144
57. Berry RE, Klumpp DJ, Schaeffer AJ (2009) Urothelial cultures support intracellular bacterial community formation by uropathogenic Escherichia coli. Infect Immun 77: 2762–2772. doi: 10.1128/IAI.00323-09 19451249
58. Linford A, Yoshimura S, Nunes Bastos R, Langemeyer L, Gerondopoulos A, et al. (2012) Rab14 and its exchange factor FAM116 link endocytic recycling and adherens junction stability in migrating cells. Dev Cell 22: 952–966. doi: 10.1016/j.devcel.2012.04.010 22595670
59. Wang J, Pantopoulos K (2011) Regulation of cellular iron metabolism. Biochem J 434: 365–381. doi: 10.1042/BJ20101825 21348856
60. Song J, Bishop BL, Li G, Duncan MJ, Abraham SN (2007) TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder. Cell Host Microbe 1: 287–298. 17710226
61. Thumbikat P, Berry RE, Zhou G, Billips BK, Yaggie RE, et al. (2009) Bacteria-induced uroplakin signaling mediates bladder response to infection. PLoS Pathog 5: e1000415. doi: 10.1371/journal.ppat.1000415 19412341
62. Eto DS, Sundsbak JL, Mulvey MA (2006) Actin-gated intracellular growth and resurgence of uropathogenic Escherichia coli. Cell Microbiol 8: 704–717. 16548895
63. Kyei GB, Vergne I, Chua J, Roberts E, Harris J, et al. (2006) Rab14 is critical for maintenance of Mycobacterium tuberculosis phagosome maturation arrest. EMBO J 25: 5250–5259. 17082769
64. Garcia EC, Brumbaugh AR, Mobley HL (2011) Redundancy and specificity of Escherichia coli iron acquisition systems during urinary tract infection. Infect Immun 79: 1225–1235. doi: 10.1128/IAI.01222-10 21220482
65. Pantopoulos K (2004) Iron metabolism and the IRE/IRP regulatory system: an update. Ann N Y Acad Sci 1012: 1–13. 15105251
66. Rittershaus ES, Baek SH, Sassetti CM (2013) The normalcy of dormancy: common themes in microbial quiescence. Cell Host Microbe 13: 643–651. doi: 10.1016/j.chom.2013.05.012 23768489
67. Gengenbacher M, Rao SP, Pethe K, Dick T (2010) Nutrient-starved, non-replicating Mycobacterium tuberculosis requires respiration, ATP synthase and isocitrate lyase for maintenance of ATP homeostasis and viability. Microbiology 156: 81–87. doi: 10.1099/mic.0.033084-0 19797356
68. Rao SP, Alonso S, Rand L, Dick T, Pethe K (2008) The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 105: 11945–11950. doi: 10.1073/pnas.0711697105 18697942
69. Touati D (2000) Iron and oxidative stress in bacteria. Arch Biochem Biophys 373: 1–6. 10620317
70. Davies MJ (2005) The oxidative environment and protein damage. Biochim Biophys Acta 1703: 93–109. 15680218
71. Imlay JA (2003) Pathways of oxidative damage. Annu Rev Microbiol 57: 395–418. 14527285
72. Andrews SC, Robinson AK, Rodriguez-Quinones F (2003) Bacterial iron homeostasis. FEMS Microbiol Rev 27: 215–237. 12829269
73. Zhao G, Ceci P, Ilari A, Giangiacomo L, Laue TM, et al. (2002) Iron and hydrogen peroxide detoxification properties of DNA-binding protein from starved cells. A ferritin-like DNA-binding protein of Escherichia coli. J Biol Chem 277: 27689–27696. 12016214
74. Wai SN, Nakayama K, Umene K, Moriya T, Amako K (1996) Construction of a ferritin-deficient mutant of Campylobacter jejuni: contribution of ferritin to iron storage and protection against oxidative stress. Mol Microbiol 20: 1127–1134. 8809765
75. Pandey R, Rodriguez GM (2012) A ferritin mutant of Mycobacterium tuberculosis is highly susceptible to killing by antibiotics and is unable to establish a chronic infection in mice. Infect Immun 80: 3650–3659. doi: 10.1128/IAI.00229-12 22802345
76. Cassat JE, Skaar EP (2013) Iron in infection and immunity. Cell Host Microbe 13: 509–519. doi: 10.1016/j.chom.2013.04.010 23684303
77. Abraham SN, Babu JP, Giampapa CS, Hasty DL, Simpson WA, et al. (1985) Protection against Escherichia coli-induced urinary tract infections with hybridoma antibodies directed against type 1 fimbriae or complementary D-mannose receptors. Infect Immun 48: 625–628. 2860067
78. Mehershahi KS, Abraham SN, Chen SL (2015) Complete Genome Sequence of Uropathogenic Escherichia coli Strain CI5. Genome Announc 3.
79. Lee AK, Falkow S (1998) Constitutive and inducible green fluorescent protein expression in Bartonella henselae. Infect Immun 66: 3964–3967. 9673287
80. Kouranti I, Sachse M, Arouche N, Goud B, Echard A (2006) Rab35 regulates an endocytic recycling pathway essential for the terminal steps of cytokinesis. Curr Biol 16: 1719–1725. 16950109
81. Messaritou G, East L, Roghi C, Isacke CM, Yarwood H (2009) Membrane type-1 matrix metalloproteinase activity is regulated by the endocytic collagen receptor Endo180. J Cell Sci 122: 4042–4048. doi: 10.1242/jcs.044305 19861500
82. Manders EMM, Verbeek FJ, Aten JA (1993) Measurement of Colocalization of Objects in Dual-Color Confocal Images. Journal of Microscopy-Oxford 169: 375–382.
83. Jones DT, Trowbridge IS, Harris AL (2006) Effects of transferrin receptor blockade on cancer cell proliferation and hypoxia-inducible factor function and their differential regulation by ascorbate. Cancer Res 66: 2749–2756. 16510596
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2015 Číslo 8
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques
- Type VI Secretion System Toxins Horizontally Shared between Marine Bacteria
- Are Human Intestinal Eukaryotes Beneficial or Commensals?
- Illuminating Targets of Bacterial Secretion